A Web-Based System for Bayesian Benchmark Dose Estimation

Background: Benchmark dose (BMD) modeling is an important step in human health risk assessment and is used as the default approach to identify the point of departure for risk assessment. A probabilistic framework for dose–response assessment has been proposed and advocated by various institutions and organizations; therefore, a reliable tool is needed to provide distributional estimates for BMD and other important quantities in dose–response assessment. Objectives: We developed an online system for Bayesian BMD (BBMD) estimation and compared results from this software with U.S. Environmental Protection Agency’s (EPA’s) Benchmark Dose Software (BMDS). Methods: The system is built on a Bayesian framework featuring the application of Markov chain Monte Carlo (MCMC) sampling for model parameter estimation and BMD calculation, which makes the BBMD system fundamentally different from the currently prevailing BMD software packages. In addition to estimating the traditional BMDs for dichotomous and continuous data, the developed system is also capable of computing model-averaged BMD estimates. Results: A total of 518 dichotomous and 108 continuous data sets extracted from the U.S. EPA’s Integrated Risk Information System (IRIS) database (and similar databases) were used as testing data to compare the estimates from the BBMD and BMDS programs. The results suggest that the BBMD system may outperform the BMDS program in a number of aspects, including fewer failed BMD and BMDL calculations and estimates. Conclusions: The BBMD system is a useful alternative tool for estimating BMD with additional functionalities for BMD analysis based on most recent research. Most importantly, the BBMD has the potential to incorporate prior information to make dose–response modeling more reliable and can provide distributional estimates for important quantities in dose–response assessment, which greatly facilitates the current trend for probabilistic risk assessment. https://doi.org/10.1289/EHP1289

[1]  Kenny S. Crump,et al.  Calculation of Benchmark Doses from Continuous Data , 1995 .

[2]  Adrian E. Raftery,et al.  Bayesian Model Averaging , 1998 .

[3]  Walter W. Piegorsch,et al.  Bayesian benchmark dose analysis , 2014, 1406.2725.

[4]  Matthew W Wheeler,et al.  Bayesian Hierarchical Structure for Quantifying Population Variability to Inform Probabilistic Health Risk Assessments , 2017, Risk analysis : an official publication of the Society for Risk Analysis.

[5]  Kan Shao,et al.  Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data , 2014, Risk analysis : an official publication of the Society for Risk Analysis.

[6]  Wout Slob,et al.  Shape and steepness of toxicological dose–response relationships of continuous endpoints , 2014, Critical reviews in toxicology.

[7]  Wasserman,et al.  Bayesian Model Selection and Model Averaging. , 2000, Journal of mathematical psychology.

[8]  K. Jarrod Millman,et al.  Python for Scientists and Engineers , 2011, Comput. Sci. Eng..

[9]  Kan Shao,et al.  Is the assumption of normality or log-normality for continuous response data critical for benchmark dose estimation? , 2013, Toxicology and applied pharmacology.

[10]  Fred A. Wright,et al.  Standardizing Benchmark Dose Calculations to Improve Science-Based Decisions in Human Health Assessments , 2014, Environmental health perspectives.

[11]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.

[12]  J. Evans,et al.  Reproductive and Developmental Risks from Ethylene Oxide: A Probabilistic Characterization of Possible Regulatory Thresholds , 2001, Risk analysis : an official publication of the Society for Risk Analysis.

[13]  Jonathan I Levy,et al.  Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[14]  Wout Slob,et al.  Dose-response modeling of continuous endpoints. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  Weihsueh A. Chiu,et al.  A Unified Probabilistic Framework for Dose–Response Assessment of Human Health Effects , 2015, Environmental health perspectives.

[16]  Jiqiang Guo,et al.  Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.

[17]  José Cortiñas Abrahantes,et al.  Update: use of the benchmark dose approach in risk assessment , 2017, EFSA journal. European Food Safety Authority.

[18]  Kan Shao,et al.  Potential Uncertainty Reduction in Model‐Averaged Benchmark Dose Estimates Informed by an Additional Dose Study , 2011, Risk analysis : an official publication of the Society for Risk Analysis.

[19]  Matthew W Wheeler,et al.  Bayesian Quantile Impairment Threshold Benchmark Dose Estimation for Continuous Endpoints , 2017, Risk analysis : an official publication of the Society for Risk Analysis.

[20]  Wout Slob,et al.  A Comparison of Three Methods for Calculating Confidence Intervals for the Benchmark Dose , 2004, Risk analysis : an official publication of the Society for Risk Analysis.

[21]  Richard N Hill,et al.  Risk Assessment For Benefits Analysis: Framework for Analysis of A Thyroid-Disrupting Chemical , 2005, Journal of toxicology and environmental health. Part A.

[22]  Xiaosong Li,et al.  Bayesian model averaging for benchmark dose estimation , 2014, Environmental and Ecological Statistics.

[23]  Matthew W Wheeler,et al.  Properties of Model‐Averaged BMDLs: A Study of Model Averaging in Dichotomous Response Risk Estimation , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[24]  Travis E. Oliphant,et al.  Python for Scientific Computing , 2007, Computing in Science & Engineering.

[25]  D Krewski,et al.  A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors. , 1999, Regulatory toxicology and pharmacology : RTP.

[26]  A. John Bailer,et al.  Quantile benchmark dose estimation for continuous endpoints , 2015 .

[27]  Tracey J. Woodruff,et al.  Estimating Risk from Ambient Concentrations of Acrolein across the United States , 2006, Environmental health perspectives.

[28]  Robert Goble,et al.  A STRAW MAN PROPOSAL FOR A QUANTITATIVE DEFINITION OF THE RfD , 2002, Drug and chemical toxicology.

[29]  Adrian E. Raftery,et al.  Bayesian model averaging: a tutorial (with comments by M. Clyde, David Draper and E. I. George, and a rejoinder by the authors , 1999 .

[30]  Adrian E. Raftery,et al.  Bayesian Model Averaging: A Tutorial , 2016 .